2024
Measuring intersectional HIV, sexual diversity, and gender non-conformity stigma among healthcare workers in Ghana: scale validation and correlates of stigma
Oga E, Stockton M, Abu-Ba’are G, Vormawor R, Mankattah E, Endres-Dighe S, Richmond R, Jeon S, Logie C, Baning E, Saalim K, Torpey K, Nelson L, Nyblade L. Measuring intersectional HIV, sexual diversity, and gender non-conformity stigma among healthcare workers in Ghana: scale validation and correlates of stigma. BMC Health Services Research 2024, 24: 647. PMID: 38773589, PMCID: PMC11110277, DOI: 10.1186/s12913-024-11098-6.Peer-Reviewed Original ResearchConceptsIntersectional stigmaIntersectional identitiesHealthcare facility staffHealthcare facilitiesGender non-conformity stigmaStigmatizing beliefsGender non-conformingSame-sex relationshipsReduce intersectional stigmaSame-gender sexFactors associated with stigmaAssociated with less stigmaMethodsWe analyzed baseline dataStigma reduction interventionsGreater comfortCorrelates of stigmaMulti-level interventionsInfection control trainingSexual diversitySexual normsAssociated with greater comfortGreater religiosityHIV testingResultsFactor analysisExploratory factor analysis
2023
Leveraging family-based assets for Black men who have sex with men in House Ball Communities: Protocol for a cluster randomized controlled trial
Birnbaum J, Roberson M, Bailey M, Smith M, Turner D, Qian H, Jeon S, Hirshfield S, Nelson L. Leveraging family-based assets for Black men who have sex with men in House Ball Communities: Protocol for a cluster randomized controlled trial. PLOS ONE 2023, 18: e0289681. PMID: 37683036, PMCID: PMC10490903, DOI: 10.1371/journal.pone.0289681.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusHouse Ball CommunityHBC familiesBlack MSMBall CommunityHIV-negative Black MSMHIV-positive Black MSMHIV pre-exposure prophylaxis (PrEP) usePre-exposure prophylaxis useNew human immunodeficiency virusADAPT-ITT modelWaitlist control armCondomless anal intercourseFamily-based interventionsBlack menProphylaxis useHIV careHIV-negativeSecondary outcomesHIV testingPrimary outcomeImmunodeficiency virusHIV treatmentPreliminary efficacyControl arm